Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anzalp Pharmasolutions is a contract research, development, and manufacturing organization (CRO/CDMO) serving the pharmaceutical, biotechnology, and agrochemical sectors. The company provides a comprehensive suite of services including medicinal chemistry, custom synthesis, and process R&D for small molecule drug discovery. Anzalp operates state-of-the-art research facilities in India while maintaining a strategic business presence in the United States to support its global client base. Their expertise extends to the development of complex intermediates, key starting materials, and active pharmaceutical ingredients (APIs). By offering integrated solutions from discovery to commercialization, Anzalp aims to accelerate the drug development timelines of its partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anzalp Pharmasolutions USA.